Acadia Pharmaceuticals
@AcadiaPharmaAcadia is trailblazing breakthroughs in science to elevate life. See our community guidelines: https://t.co/WgyqXbokJG
Similar User
@BioXcel_Tx
@RettUniversity
@Crinetics
@StokeTx
@AvanceCRO
@DrDaniAndrade
@CytoSorbents
@RettDad
@amicusrx1
@ApellisPharma
@Nutcracker_Tx
@SistersHopeALSP
@GalaxyBeams
@Alushin_Lab
@CNSdrughunter
We’re heading to Spain to present data on #RettSyndrome at #ISPOREurope. We appreciate the opportunity to connect with researchers focused on advancing scientific evidence in understanding & improving the health and well-being of people across the globe. bit.ly/3CpOXMi.
We look forward to joining the 53rd @ChildNeuroSoc Annual Meeting next week here in San Diego, CA, where we will be connecting with researchers on the latest advancements in child neurology. Learn more: bit.ly/3DW2yde. #CNSAM
Today, we shared our Q3 2024 #earnings results. Read our $ACAD financial summary and key updates here: bit.ly/3NZ25dS.
We’re attending the 20th annual @neiglobal #NEICongress and look forward to discussing our latest findings in #ParkinsonsDisease with professionals in psychiatry and mental health during this enriching educational event. Learn more: bit.ly/47kK2qk.
We’re looking forward to attending the 37th Psych Congress this week where we’ll have the opportunity to share our latest #ParkinsonsDisease research with the mental health community. Learn more and register here: bit.ly/4dW4ZKZ.
Today we announced that Health Canada has granted marketing authorization for our #RettSyndrome treatment, the first and only drug approved in Canada for the treatment of Rett syndrome. Learn more: bit.ly/3UdhdIi.
We’re looking forward to learning about the latest in managed care at @amcporg Nexus 2024 in Las Vegas next week. Learn more: amcpnexus.org. #AMCPNexus
We’re heading to Australia next week to share our latest findings in #RettSyndrome at the 9th World Rett Syndrome Congress. We’re looking forward to connecting with experts & families from the international Rett community. Learn more: bit.ly/4ej0QC5. #rettworldcongress
We’re looking forward to attending several conferences this week where we'll have the opportunity to share our latest findings in the therapeutic areas we are committed to and connect with the various communities we serve.
Today we announced Catherine Owen Adams has succeeded Steve Davis as Acadia's Chief Executive Officer (CEO) and joined the Acadia Board of Directors. Learn more here: bit.ly/4ejMrW7
We’re looking forward to presenting at a number of #investor conferences this coming month: Morgan Stanley 22nd Annual Global Healthcare Conference & Baird 2024 Global Healthcare Conference. Learn about our participation: bit.ly/474eW7m $ACAD
Today we announced the launch of #MoretoParkinsons, a disease education campaign to raise awareness among caregivers, patients and their care providers about #ParkinsonsDisease-related hallucinations and delusions. Read more here: bit.ly/3M513wc
Today, we shared our Q2 2024 #earnings results. Read our $ACAD financial summary and key updates here: bit.ly/3SDimIi.
We’re excited to be at the @alzassociation International Conference this weekend. We look forward to connecting with the #alzheimers community while diving into a scientific program dedicated to advancing dementia science. Learn more: bit.ly/3pLO7no #AAIC24
Today we announced that the journal Med published clinical data evaluating long-term safety and efficacy of our treatment option for patients with #RettSyndrome. Learn more: bit.ly/3LvY93e.
We're grateful to our talented Acadian contributors as we celebrate our anniversary of our listing on @Nasdaq We look forward to continuing to work together to blaze trails for the patient communities we serve. Interested in joining our team? Learn more: bit.ly/3WbnJiO.
We look forward to attending the 10th congress of the @EANeurology this weekend where we’ll be presenting our latest research in #RettSyndrome. Learn more about the event here: bit.ly/3L2WdPp #EAN2024
Today, we will be presenting several new posters at the 2024 @Rettsyndrome (IRSF) Annual Scientific Meeting, including interim data from our open-label real-world study. Learn more: bit.ly/3VNiffa. #RettSyndrome
We’re heading to Westminster, Colorado tomorrow for the @Rettsyndrome ASCEND 2024 Rett Syndrome National Summit. We look forward to connecting with families, clinicians, researchers, & organizations in the Rett community from around the world. Learn more: bit.ly/3VKWMDB.
Thank you to the @ipwso for the opportunity to participate in this year’s 6th International Prader-Willi Syndrome Caregivers’ Conference. We are grateful for the opportunity to connect with professional #PraderWilli syndrome caregivers from around the world. #PWSCare24
United States Trends
- 1. Tyson 478 B posts
- 2. $MAYO 13 B posts
- 3. #wompwomp 5.628 posts
- 4. Pence 59,2 B posts
- 5. Syracuse 13,8 B posts
- 6. Paige 5.974 posts
- 7. Kiyan 17,3 B posts
- 8. Debbie 33,5 B posts
- 9. Kash 99,7 B posts
- 10. The FBI 264 B posts
- 11. Iron Mike 21,1 B posts
- 12. Whoopi 108 B posts
- 13. Dora 24,4 B posts
- 14. #LetsBONK 14,9 B posts
- 15. Shu Shu 27,2 B posts
- 16. Connor Williams 1.443 posts
- 17. Ronaldo 190 B posts
- 18. Mike Rogers 20,1 B posts
- 19. Gabrielle Union 2.218 posts
- 20. #Boxing 19 B posts
Who to follow
-
BioXcel Therapeutics (Nasdaq: BTAI)
@BioXcel_Tx -
Rett University
@RettUniversity -
Crinetics Pharmaceuticals
@Crinetics -
Stoke Therapeutics
@StokeTx -
Avance Clinical
@AvanceCRO -
AGE Program - Adult Genetic Epilespy
@DrDaniAndrade -
CytoSorbents
@CytoSorbents -
Rett Dad
@RettDad -
Amicus Therapeutics
@amicusrx1 -
Apellis Pharma
@ApellisPharma -
Nutcracker Therapeutics
@Nutcracker_Tx -
Sisters' Hope Foundation
@SistersHopeALSP -
Lane
@GalaxyBeams -
Alushin_Lab
@Alushin_Lab -
Ana Mingorance
@CNSdrughunter
Something went wrong.
Something went wrong.